SR Medical Technology Company Limited (HKG:0108)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.650
+0.100 (6.45%)
Jul 31, 2026, 4:08 PM HKT

HKG:0108 Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
327.91327.91310.02352.64352.28331.34
Revenue Growth
8.39%5.77%-12.09%0.10%6.32%9.88%
Net Income
-109.63-109.63-918.5-129.31-320.13207.63
Earnings Per Share
-0.03-0.03-0.29-0.04-0.100.05
EPS Growth
-----26513.95%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Property Development and Investment
140.98140.98140.2148.02133.67126.18
Property Management
186.94186.94169.82204.62218.61205.15
Total
327.91327.91310.02352.64352.28331.34

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
121.22121.22193.15316.82360.68304.05
Total Debt
2,8902,8902,6532,6962,3862,166
Net Cash (Debt)
-2,769-2,769-2,460-2,379-2,025-1,862
Net Cash Growth
------
Net Cash Per Share
-0.86-0.86-0.76-0.74-0.63-0.41

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
121.78121.7885.49122.57-106.3647.59
Free Cash Flow
121.78121.7885.49122.57-106.3647.59
Free Cash Flow Growth
83.28%42.45%-30.25%--1142.53%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
19.88%19.88%23.98%39.66%35.62%5.80%
Pretax Margin
-41.38%-41.38%-312.08%-19.84%-94.89%40.18%
Profit Margin
-33.43%-33.43%-296.27%-36.67%-90.87%62.66%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----15.56
PS Ratio
16.2122.888.152.908.549.75